Status:

UNKNOWN

Comparison of Slow Efficiency Daily Dialysis (SLEDD) With Unfractionated Heparin Versus Citrasate in Critically Ill Patients.

Lead Sponsor:

University Hospital, Antwerp

Conditions:

Acute Kidney Injury

Hemodialysis

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to compare the feasibility, safety and efficacy of hemodialysis with unfractionated heparin compared to hemodialysis with Citrasate in Critically Ill Patients.

Detailed Description

Objective : To compare the feasibility, safety and efficacy of Sustained Low Efficiency Daily Hemodialysis (SLEDD) using regional anticoagulation with Citrasate® compared to systemic anticoagulation w...

Eligibility Criteria

Inclusion

  • Need for hemodialysis in the ICU for at least one treatment
  • No prior hemodialysis treatment in the ICU except continuous renal replacement therapy

Exclusion

  • Need for systemic anticoagulation with unfractionated or fractionated heparin, oral anticoagulants or intravenous anti-aggregants for other reasons
  • Need for continued thrombolysis therapy within the 6 hours before inclusion
  • Need for continued treatment with activated protein C (drotrecogin alfa) within the 12 hours before inclusion
  • Need for continued treatment with intravenous anti-aggregants (abciximab, eptifabide) within 12 hours before inclusion
  • Liver failure (acute and acute-on-chronic)
  • Confirmed or suspected Heparin Induced Thrombocytopenia (HIT)
  • Heparin allergies
  • Severe uncorrected hypocalcemia (ionized calcium \< 0,8 mmol/l)
  • Refusal of informed consent

Key Trial Info

Start Date :

January 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2013

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT01228292

Start Date

January 1 2011

End Date

January 1 2013

Last Update

October 26 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Critical Care Department of the Antwerp University Hospital, Belgium

Edegem, Edegem, Belgium, 2650